22nd Century Group (NASDAQ:XXII) Shares Scheduled to Reverse Split on Tuesday, April 2nd

22nd Century Group, Inc. (NASDAQ:XXII) shares are going to reverse split on Tuesday, April 2nd. The 1-16 reverse split was announced on Tuesday, April 2nd. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, April 2nd.

22nd Century Group Stock Down 8.7 %

Shares of XXII stock traded down $0.01 on Friday, reaching $0.12. 3,495,353 shares of the company’s stock traded hands, compared to its average volume of 1,216,440. The company has a market capitalization of $3.71 million, a P/E ratio of -0.01 and a beta of 1.54. 22nd Century Group has a 12-month low of $0.10 and a 12-month high of $12.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.62 and a current ratio of 1.02. The business’s 50 day moving average price is $0.15 and its two-hundred day moving average price is $0.36.

Hedge Funds Weigh In On 22nd Century Group

Institutional investors and hedge funds have recently bought and sold shares of the business. AQR Capital Management LLC purchased a new position in shares of 22nd Century Group during the 2nd quarter valued at $26,000. ExodusPoint Capital Management LP purchased a new position in 22nd Century Group in the second quarter valued at about $36,000. Renaissance Technologies LLC acquired a new position in 22nd Century Group in the 1st quarter worth about $40,000. Virtu Financial LLC purchased a new stake in shares of 22nd Century Group during the 1st quarter worth about $41,000. Finally, First Western Trust Bank purchased a new stake in shares of 22nd Century Group during the 1st quarter worth about $43,000. Hedge funds and other institutional investors own 18.06% of the company’s stock.

About 22nd Century Group

22nd Century Group, Inc, an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.